Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid derived in
methionine metabolism. The increased level of Hcy in plasma, hyperhomocysteinemia, is …

This review discussed and in particular emphasis the potential cellular pathways and the
biological processes involved that lead to homocysteine-induced endothelial dysfunction, in …

Background Cardiovascular disease, which includes coronary artery disease, stroke and
peripheral vascular disease, is a leading cause of death worldwide. Homocysteine is an …

Oxidant–antioxidant imbalance is involved in the etiology of different diseases, including
cardiovascular diseases (CVDs), liver disorders, kidney diseases, cancers and diabetes …

Homocysteine is a sulphur‐containing non‐proteinogenic amino acid.
Hyperhomocysteinaemia (HHcy), the pathogenic elevation of plasma homocysteine as a …

Homocysteine (Hcy) is a sulfhydryl-containing amino acid, which is not acquired through the
diet, but rather synthesized as an intermediate metabolite in the methionine cycle. Hcy is …

Hyperhomocysteinemia, an increased level of plasma homocysteine, is an independent risk
factor for the development of premature arterial fibrosis with peripheral and cerebro …

The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains
unclear. HHCy is associated with inflammation and atherosclerosis, and it is an independent …

B vitamin therapy lowers plasma total homocysteine concentrations, and might be a
beneficial intervention for stroke prevention; however, cyanocobalamin (a form of vitamin …

Homocystinuria (HCU) refers to a group of inherited disorders of homocysteine metabolism
associated with high blood homocysteine concentration, thromboembolic tendency and …